Cargando…
Oridonin induces growth inhibition and apoptosis in human gastric carcinoma cells by enhancement of p53 expression and function
The tumor suppressive role of oridonin, an active compound extracted from Rabdosia rubescens, has been proven in several gastric cancer (GC) cell lines. The present study aimed to evaluate the effect of oridonin on another GC cell line, SNU-216, and explore the potential mechanisms. The viable cell...
Autores principales: | Bi, Enxu, Liu, Dengqiang, Li, Youxi, Mao, Xuying, Wang, Aihua, Wang, Jingtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247279/ https://www.ncbi.nlm.nih.gov/pubmed/30462771 http://dx.doi.org/10.1590/1414-431X20187599 |
Ejemplares similares
-
Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms
por: Shi, Min, et al.
Publicado: (2016) -
Oridonin Dose-Dependently Modulates the Cell Senescence and Apoptosis of Gastric Cancer Cells
por: Wang, Yiping, et al.
Publicado: (2021) -
Oridonin induces Mdm2‐p60 to promote p53‐mediated apoptosis and cell cycle arrest in neuroblastoma
por: Zhu, Han‐Qing, et al.
Publicado: (2019) -
Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells
por: Yao, Zhuo, et al.
Publicado: (2017) -
Solubility and Bioavailability Enhancement of Oridonin: A Review
por: Zhang, Yuanyuan, et al.
Publicado: (2020)